Amgen CEO Robert A. Bradway Becomes PhRMA Board Chairman

Olivier Brandicourt, CEO, Sanofi, James Robinson, president, Astellas Americas, assume new postsWashington, D.C. (February 7, 2018) — The Pharmaceutical Research and Manufacturers of America (PhRMA) held its board meeting today, officially welcoming three new elected officers. Robert A. Bradway, chairman and CEO, Amgen, became chairman of the PhRMA board of directors. Olivier Brandicourt, CEO, Sanofi was named chairman-elect and James Robinson, president, Astellas Americas assumed the role of board treasurer.Bradway formerly held the position of board treasurer and succeeds Joaquin Duato, executive vice president and worldwide chairman, pharmaceuticals, Johnson & Johnson as ...

Source: Amgen News Release - February 7, 2018 Category: Pharmaceuticals Tags: Uncategorized Source Type: news